Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN
EPICLIN
1 other identifier
observational
3,513
8 countries
162
Brief Summary
To provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of: patient and hospital characteristics; diagnostic and treatment approaches: initial and subsequent, follow-up patterns in clinical management; outcomes: symptoms, death, functionality, quality of life; use of resources and burden on patients and health care systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
162 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 28, 2009
CompletedFirst Posted
Study publicly available on registry
January 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedAugust 10, 2010
August 1, 2010
1.5 years
January 28, 2009
August 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To provide accurate, reliable information on NSCLC clinical management across European countries in order to detect unmet medical needs of this disease
1 year follow up
Secondary Outcomes (5)
To assess the differences in patient characteristics, disease stage (differentiating between non-advanced disease, locally advanced disease, metastatic disease), and in clinical management across European countries.
1 year follow up
To detect differences in clinical outcomes and related factors among countries.
1 year follow up
To identify factors associated with clinical outcomes (patient, disease stage and clinical management related factors): predictive modelling for improved patient outcome.
1 year follow up
To identify factors associated with the different levels of functional status and quality of life.
1 year follow up
To compare the use of health care resources among countries.
1 year follow up
Study Arms (1)
1
All NSCLC patients attending the responsible department of treating this type of patients (e.g. Oncology Department, Pneumology Department) for the first time (regardless of whether the patient is diagnosed with locally, advanced or metastatic disease) at the participating sites from the first of January 2009 to the end of March 2009. Patients diagnosed, or even treated, in other departments within the same hospital or in another hospital are susceptible to be included in the study if full access to the patient's medical record is made available.
Eligibility Criteria
All NSCLC patients attending the responsible department of treating this type of patients (e.g. Oncology Department, Pneumology Department) for the first time (regardless of whether the patient is diagnosed with locally, advanced or metastatic disease) at the participating sites from the first of January 2009 to the end of March 2009. Patients diagnosed, or even treated, in other departments within the same hospital or in another hospital are susceptible to be included in the study if full access to the patient's medical record is made available.
You may qualify if:
- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between January 1st, 2009 and March 31st, 2009.
- For PRO sub-sample: ability to read and write since they will be asked to participate in the PRO part of the study. Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (162)
Research Site
Antwerp, Belgium
Research Site
Brussels, Belgium
Research Site
Genk, Belgium
Research Site
Herstal, Belgium
Research Site
Liège, Belgium
Research Site
Aix-en-Provence, France
Research Site
Ambilly, France
Research Site
Antibes, France
Research Site
Aulnay-sous-Bois, France
Research Site
Bar-le-Duc, France
Research Site
Beauvais, France
Research Site
Beuvry, France
Research Site
Bordeaux, France
Research Site
Brest, France
Research Site
Cahors, France
Research Site
Castelnau-le-Lez, France
Research Site
Chalon-sur-Saône, France
Research Site
Chauny, France
Research Site
Chevilly-Larue, France
Research Site
Cholet, France
Research Site
Clamart, France
Research Site
Colmar, France
Research Site
Compiègne, France
Research Site
Coulommiers, France
Research Site
Denain, France
Research Site
Dijon, France
Research Site
Douai, France
Research Site
Draguignan, France
Research Site
Épinal, France
Research Site
Flers, France
Research Site
Givors, France
Research Site
Granville, France
Research Site
Grasse, France
Research Site
Guingamp, France
Research Site
Hyères, France
Research Site
Jonzac, France
Research Site
La Ferté-Bernard, France
Research Site
La Rochelle, France
Research Site
La Tronche, France
Research Site
Le Mans, France
Research Site
Liévin, France
Research Site
Limoges, France
Research Site
Longjumeau, France
Research Site
Lyon, France
Research Site
Mantes-la-Jolie, France
Research Site
Martigues, France
Research Site
Meaux, France
Research Site
Metz, France
Research Site
Metz-Tessy, France
Research Site
Mont-de-Marsan, France
Research Site
Mont-Saint-Martin, France
Research Site
Montpellier, France
Research Site
Moulins, France
Research Site
Mulhouse, France
Research Site
Nancy, France
Research Site
Nevers, France
Research Site
Nice, France
Research Site
Nîmes, France
Research Site
Oloron-Sainte-Marie, France
Research Site
Paris, France
Research Site
Perpignan, France
Research Site
Pierre-Bénite, France
Research Site
Pontoise, France
Research Site
Quimper, France
Research Site
Rambouillet, France
Research Site
Reims, France
Research Site
Rennes, France
Research Site
Saint-Aubin-lès-Elbeuf, France
Research Site
Saint-Priest-en-Jarez, France
Research Site
Saverne, France
Research Site
Soissons, France
Research Site
Strasbourg, France
Research Site
Thonon-les-Bains, France
Research Site
Toulon, France
Research Site
Toulon Armees, France
Research Site
Toulouse, France
Research Site
Valence, France
Research Site
Vandœuvre-lès-Nancy, France
Research Site
Verdun, France
Research Site
Vesoul, France
Research Site
Vire, France
Research Site
Heidelberg, Baden W�rttemberg, Germany
Research Site
Ulm, Baden-W�rtemberg, Germany
Research Site
Löwenstein, Baden-W�rttemberg, Germany
Research Site
Munchen-Gauting, Bavaria, Germany
Research Site
Harburg, Hamburg, Germany
Research Site
Essen, North Rhine-Westphalia, Germany
Research Site
Hemer, North Rhine-Westphalia, Germany
Research Site
Leipzig, Saxony, Germany
Research Site
Halle, Saxony-Anhalt, Germany
Research Site
Gro�hansdorf, Schleswig-Holstein, Germany
Research Site
Athens, Athens, Greece
Research Site
Heraklio, Crete, Greece
Research Site
Ioannina, Ioannina, Greece
Research Site
Pátrai, Patra, Greece
Research Site
Piraeus, Piraeus, Greece
Research Site
Thessaloniki, Thessaloniki, Greece
Research Site
Bologna, Italy
Research Site
Brindisi, Italy
Research Site
Carpi, Italy
Research Site
Cattolica, Italy
Research Site
Cesena, Italy
Research Site
Cremona, Italy
Research Site
Faenza, Italy
Research Site
Fano, Italy
Research Site
Legnano, Italy
Research Site
Lido di Camaiore, Italy
Research Site
Lugo, Italy
Research Site
Mantova, Italy
Research Site
Meldola, Italy
Research Site
Milan, Italy
Research Site
Napoli, Italy
Research Site
Parma, Italy
Research Site
Perugia, Italy
Research Site
Ravenna, Italy
Research Site
Rimini, Italy
Research Site
S. Giovanni Rotondo, Italy
Research Site
Saronno, Italy
Research Site
Sondrio, Italy
Research Site
Verona, Italy
Research Site
Lisbon, Portugal
Research Site
Ponta Delgada, Portugal
Research Site
Porto, Portugal
Research Site
Sta.Ma Feira, Portugal
Research Site
V.N: de Gaia, Portugal
Research Site
Madrid, Madrid, Spain
Research Site
Santa Cruz de Tenerife, Tenerife, Spain
Research Site
A Coruña, Spain
Research Site
Alicante, Spain
Research Site
Barcelona, Spain
Research Site
Cabueñes, Spain
Research Site
Calella, Spain
Research Site
Castellon, Spain
Research Site
Córdoba, Spain
Research Site
Cuenca, Spain
Research Site
Elche, Spain
Research Site
Jaén, Spain
Research Site
León, Spain
Research Site
Lleida, Spain
Research Site
Madrid, Spain
Research Site
Manacor, Spain
Research Site
Mataró, Spain
Research Site
Málaga, Spain
Research Site
Melilla, Spain
Research Site
Oviedo, Spain
Research Site
Palma de Mallorca, Spain
Research Site
Pamplona, Spain
Research Site
Puerto Real, Spain
Research Site
Sagunto, Spain
Research Site
Salamanca, Spain
Research Site
Santa Cruz de Tenerife, Spain
Research Site
Seville, Spain
Research Site
Tudela, Spain
Research Site
Valencia, Spain
Research Site
Xàtiva, Spain
Research Site
Zaragoza, Spain
Research Site
Adana, Turkey (Türkiye)
Research Site
Ankara, Turkey (Türkiye)
Research Site
Gaziantep, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Izmir, Turkey (Türkiye)
Research Site
Konya, Turkey (Türkiye)
Related Publications (2)
Vergnenegre A, Carrato A, Thomas M, Jernigan C, Medina J, Cruciani G. Real-world healthcare resource utilization in a European non-small cell lung cancer population: the EPICLIN-Lung study. Curr Med Res Opin. 2014 Mar;30(3):463-70. doi: 10.1185/03007995.2013.860373. Epub 2013 Nov 18.
PMID: 24188056DERIVEDCarrato A, Vergnenegre A, Thomas M, McBride K, Medina J, Cruciani G. Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study. Curr Med Res Opin. 2014 Mar;30(3):447-61. doi: 10.1185/03007995.2013.860372. Epub 2013 Nov 18.
PMID: 24168104DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alfredo Carrato, MD
Hospital Ramón y Cajal, Madrid (Spain)
- STUDY DIRECTOR
Esteban Medina
Medical Department, AstraZeneca Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 28, 2009
First Posted
January 29, 2009
Study Start
January 1, 2009
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
August 10, 2010
Record last verified: 2010-08